Search by Drug Name or NDC
NDC 39822-0310-05 Neomycin Sulfate 500 mg/1 Details
Neomycin Sulfate 500 mg/1
Neomycin Sulfate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by XGen Pharmaceuticals DJB, Inc.. The primary component is NEOMYCIN SULFATE.
Product Information
| NDC | 39822-0310 |
|---|---|
| Product ID | 39822-0310_f98e5359-9315-9f38-e053-6294a90a2ba0 |
| Associated GPIs | 07000040100305 |
| GCN Sequence Number | 009284 |
| GCN Sequence Number Description | neomycin sulfate TABLET 500 MG ORAL |
| HIC3 | W1F |
| HIC3 Description | AMINOGLYCOSIDE ANTIBIOTICS |
| GCN | 41072 |
| HICL Sequence Number | 004029 |
| HICL Sequence Number Description | NEOMYCIN SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Neomycin Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Neomycin Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | NEOMYCIN SULFATE |
| Labeler Name | XGen Pharmaceuticals DJB, Inc. |
| Pharmaceutical Class | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065220 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 39822-0310-05 (39822031005)
| NDC Package Code | 39822-0310-5 |
|---|---|
| Billing NDC | 39822031005 |
| Package | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (39822-0310-5) / 1 TABLET in 1 BLISTER PACK (39822-0310-7) |
| Marketing Start Date | 2010-03-12 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.88756 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | NEOMYCIN 500 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis